Japan draws up nephropathy diagnoses guidelines:
This article was originally published in Clinica
Executive Summary
An expert group in Japan has begun drawing up guidelines for the diagnosis and treatment of diabetic nephropathy. This follows the discovery that there are wide variations across the country in the interpretation of microalbuminuria test results. The group plans to establish standard ranges for urine microalbumin, register all patients in Japan with diabetic nephropathy and undertake a five-year follow-up patient study, reports Pharma Japan.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.